Reply to "Fatal reactions to alpha-gal might be due to comorbid mast cell diseases" [0.03%]
对“α-Gal严重过敏反应可能是伴发肥大细胞疾病所致”的回复
Thomas A E Platts-Mills,Lisa J Workman,Nathan E Richards et al.
Thomas A E Platts-Mills et al.
Fatal reactions to alpha-gal might be due to comorbid mast cell diseases [0.03%]
α-Gal过敏的重症反应或与伴随发生的肥大细胞疾病有关
Jason Moraczewski,Cosby A Stone Jr
Jason Moraczewski
Supporting Infants With Severe Combined Immunodeficiency and Their Mothers During Breastfeeding Cessation Due to Cytomegalovirus Risk [0.03%]
因巨细胞病毒感染风险停止母乳喂养的重度联合免疫缺陷婴儿及其母亲的心理支持
Leah Thomas,Rani Bhatia,Kahn Preece et al.
Leah Thomas et al.
Jing Yi Sun,Heather Sun,Scott H Sicherer
Jing Yi Sun
Steps Toward Change: Identifying Responders to a Physical Activity Intervention in Moderate-to-Severe Asthma [0.03%]
走向改变的步伐——识别中重度哮喘患者身体活动干预的反应者
Paola D Urroz Guerrero,Vanessa M McDonald
Paola D Urroz Guerrero
Asthma and Depression in Older Adults-A Step Closer to Understanding the Complicated Relationship [0.03%]
哮喘与老年人抑郁症-更进一步了解这种复杂关系
Alan P Baptist,Stephanie Latshaw
Alan P Baptist
David W Denning
David W Denning
Counselling for Food Allergies: What Tests to Order, What Diet to Advise and What Treatments to Offer? [0.03%]
如何进行食物过敏咨询：该进行哪些检查？建议什么饮食？提供何种治疗？
Ting F Leung,Hugh A Sampson
Ting F Leung
Brent Anderson,Claire Pascal,M Gohazrua K Butler et al.
Brent Anderson et al.
The US Food and Drug Administration approval of omalizumab for the treatment of food allergy has opened the door for therapeutics targeting the underlying mechanisms that drive food allergy. Here we discuss both approved and novel investiga...
Correction [0.03%]
改正错误